177 related articles for article (PubMed ID: 6302725)
1. Chronic elevation of brain GABA by gamma-vinyl GABA treatment does not alter the sensitivity of GABAergic or dopaminergic receptors in rat CNS.
Gardner CR; Mallorga P; Klein J; Huot-Olivier S; Palfreyman MG
Psychopharmacology (Berl); 1983; 79(2-3):130-6. PubMed ID: 6302725
[TBL] [Abstract][Full Text] [Related]
2. Subchronic administration of GABAergic agonists elevates [3H]GABA binding and produces tolerance in striatal dopamine catabolism.
Beart PM; Scatton B; Lloyd KG
Brain Res; 1985 May; 335(1):169-73. PubMed ID: 4005541
[TBL] [Abstract][Full Text] [Related]
3. Influence of supidimide on brain neurotransmitter systems of rats and mice.
Hennies HH; Günzler WA; Flohé L
Arzneimittelforschung; 1984; 34(11):1471-80. PubMed ID: 6084511
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
[TBL] [Abstract][Full Text] [Related]
5. The effects of chronic haloperidol administration on GABA receptor binding.
Huffman RD; Ticku MK
Pharmacol Biochem Behav; 1983 Aug; 19(2):199-204. PubMed ID: 6314387
[TBL] [Abstract][Full Text] [Related]
6. Actions of GABAergic agents on dopamine metabolism in the nigrostriatal pathway of the rat.
Wood PL
J Pharmacol Exp Ther; 1982 Sep; 222(3):674-9. PubMed ID: 6286931
[TBL] [Abstract][Full Text] [Related]
7. The action of gamma-vinyl-GABA and gamma-acetylenic-GABA on the resting and stimulated release of GABA in vivo.
Abdul-Ghani AS; Coutinho-Netto J; Bradford HF
Brain Res; 1980 Jun; 191(2):471-81. PubMed ID: 7378767
[TBL] [Abstract][Full Text] [Related]
8. Acute effects of gamma-vinyl GABA on the GABAergic system in rats as studied by microdialysis.
Jolkkonen J; Mazurkiewicz M; Lahtinen H; Riekkinen P
Eur J Pharmacol; 1992 Dec; 229(2-3):269-72. PubMed ID: 1490526
[TBL] [Abstract][Full Text] [Related]
9. Cerebral dopamine function in rats following withdrawal from one year of continuous neuroleptic administration.
Clow A; Theodorou A; Jenner P; Marsden CD
Eur J Pharmacol; 1980 May; 63(2-3):145-57. PubMed ID: 6103814
[TBL] [Abstract][Full Text] [Related]
10. Diazepam stimulates the binding of GABA and muscimol but not THIP to rat brain membranes.
Skerritt JH; Johnston GA
Neurosci Lett; 1983 Aug; 38(3):315-20. PubMed ID: 6314189
[TBL] [Abstract][Full Text] [Related]
11. Development of tolerance to the effects of vigabatrin (gamma-vinyl-GABA) on GABA release from rat cerebral cortex, spinal cord and retina.
Neal MJ; Shah MA
Br J Pharmacol; 1990 Jun; 100(2):324-8. PubMed ID: 2379037
[TBL] [Abstract][Full Text] [Related]
12. Effect of gamma-vinyl gamma-aminobutyric acid on the gamma-aminobutyric acid receptor-coupled chloride ion channel in vesicles from the brain of the rat.
Suzuki Y; Mimaki T; Arai H; Okada S; Kuriyama K
Neuropharmacology; 1991 May; 30(5):423-7. PubMed ID: 1650926
[TBL] [Abstract][Full Text] [Related]
13. Effect of ethanol on gamma-vinyl GABA-induced GABA accumulation in the substantia nigra and on synaptosomal GABA content in six rat brain regions.
Frye GD; Fincher AS
Brain Res; 1988 May; 449(1-2):71-9. PubMed ID: 3395859
[TBL] [Abstract][Full Text] [Related]
14. Behavioural and biochemical alterations in the function of dopamine receptors following repeated administration of L-DOPA to rats.
Hall MD; Cooper DR; Fleminger S; Rupniak NM; Jenner P; Marsden CD
Neuropharmacology; 1984 May; 23(5):545-53. PubMed ID: 6539859
[TBL] [Abstract][Full Text] [Related]
15. Effects of the gamma-aminobutyrate transaminase inhibitors gabaculine and gamma-vinyl GABA on gamma-aminobutyric acid release from slices of rat cerebral cortex.
Bedwani JR; Mehta A
Neurochem Res; 1987 Jan; 12(1):49-52. PubMed ID: 3574587
[TBL] [Abstract][Full Text] [Related]
16. Anticonvulsant and proconvulsant effects of inhibitors of GABA degradation in the amygdala-kindling model.
Löscher W; Jäckel R; Müller F
Eur J Pharmacol; 1989 Apr; 163(1):1-14. PubMed ID: 2744084
[TBL] [Abstract][Full Text] [Related]
17. Effects of the potentiation of the GABAergic neurotransmission in the olfactory bulbs on mouse-killing behavior.
Molina V; Ciesielski L; Gobaille S; Mandel P
Pharmacol Biochem Behav; 1986 Mar; 24(3):657-64. PubMed ID: 3010337
[TBL] [Abstract][Full Text] [Related]
18. SCH 23390 may alter dopamine-mediated motor behaviour via striatal D-1 receptors.
Boyce S; Kelly E; Davis A; Fleminger S; Jenner P; Marsden CD
Biochem Pharmacol; 1985 May; 34(10):1665-9. PubMed ID: 2988552
[TBL] [Abstract][Full Text] [Related]
19. Effects of vigabatrin (gamma-vinyl GABA) on neurotransmission-related amino acids and on GABA and benzodiazepine receptor binding in rats.
Halonen T; Pitkänen A; Saano V; Riekkinen PJ
Epilepsia; 1991; 32(2):242-9. PubMed ID: 1672276
[TBL] [Abstract][Full Text] [Related]
20. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
Thomas KL; Rose S; Jenner P; Marsden CD
Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
